Jupiter Neurosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JUNS and other ETFs, options, and stocks.About JUNS
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol.
CEOChrister Rosén
CEOChrister Rosén
Employees4
Employees4
HeadquartersJupiter, Florida
HeadquartersJupiter, Florida
Founded2015
Founded2015
Employees4
Employees4
JUNS Key Statistics
Market cap38.90M
Market cap38.90M
Price-Earnings ratio-5.01
Price-Earnings ratio-5.01
Dividend yield—
Dividend yield—
Average volume31.15K
Average volume31.15K
High today$1.16
High today$1.16
Low today$1.13
Low today$1.13
Open price$1.14
Open price$1.14
Volume38.07K
Volume38.07K
52 Week high$19.51
52 Week high$19.51
52 Week low$0.51
52 Week low$0.51
Stock Snapshot
As of today, Jupiter Neurosciences(JUNS) shares are valued at $1.13. The company's market cap stands at 38.9M, with a P/E ratio of -5.01.
On 2025-12-09, Jupiter Neurosciences(JUNS) stock traded between a low of $1.13 and a high of $1.16. Shares are currently priced at $1.13, which is 0.0% above the low and -2.6% below the high.
The Jupiter Neurosciences(JUNS)'s current trading volume is 38.07K, compared to an average daily volume of 31.15K.
During the past year, Jupiter Neurosciences(JUNS) stock moved between $0.51 at its lowest and $19.51 at its peak.
During the past year, Jupiter Neurosciences(JUNS) stock moved between $0.51 at its lowest and $19.51 at its peak.
People also own
Based on the portfolios of people who own JUNS. This list is generated using Robinhood data, and it’s not a recommendation.